Yangming Wang is a Principal Investigator at the Institute of Molecular Medicine at Peking University. He studies the function of noncoding RNAs-the dark matter of our genome-and stem cells that hold the potential to cure a variety of diseases such as diabetes and neurodegenerative diseases.

He has published more than 30 articles and written several book chapters in RNA biology and stem cell biology. He is interested in the impact of cutting-edge biotechnology development such as genome editing, DNA sequencing, and genetic diagnosis, and stem cell therapy on human society.

He holds a Ph.D. from the University of Illinois at Urbana-Champaign. In 2019-20, he is a Berggruen Fellow at Berggruen China Center.